Reply: Revisiting the use of albumin in patients with cirrhosis – trial design matters

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-03-12 DOI:10.1016/j.jhep.2025.03.006

Marten A. Lantinga, Elliot B. Tapper, Joost P.H. Drenth

引用次数: 0

Abstract

Section snippets

Uncited reference

Authors' contributions

All authors contributed equally to the conception, design, and writing of the article.

Financial support

None.

Declaration of Competing Interest

The authors declare that they have no competing interests.Please refer to the accompanying ICMJE disclosure forms for further details.

查看原文本刊更多论文

回复：重新审视白蛋白在肝硬化患者中的应用——试验设计问题

引用的参考文献8。作者的贡献所有作者对文章的构思、设计和写作都做出了同等的贡献。金融supportNone。竞争利益声明作者声明他们没有竞争利益。详情请参阅随附的ICMJE披露表格。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.